Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways
Martha López-Canul(Montreal Neurological Institute and Hospital), Gabriella Gobbi(McGill University), Gilberto Spadoni(University of Urbino), Enza Palazzo(University of Campania "Luigi Vanvitelli"), Debora Angeloni(Scuola Superiore Sant'Anna), Serena Boccella(University of Campania "Luigi Vanvitelli"), Annalida Bedini(University of Urbino), Livio Luongo(University of Campania "Luigi Vanvitelli"), Baptiste Lacoste(University of Ottawa), Sergio Domínguez-López(McGill University Health Centre), Sabatino Maione(University of Campania "Luigi Vanvitelli"), Vinicio Granados‐Soto(Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional), Giorgio Tarzia(Université de Montréal), F. Fraschini(University of Milan), Stefano Comai(University of Padua)
Cited by 94
Related Papers
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
|Pharmacological Reviews|2018|386
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
|Nature Neuroscience|2006|373